Synthesis and biological evaluation of ortho-phenyl phenylhydroxamic acids containing phenothiazine with improved selectivity for class IIa histone deacetylases
Class IIa histone deacetylases (HDACs) have been linked to tumorigenesis in various cancers. Previously, we designed phenylhydroxamic acid LH4f as a potent class IIa HDAC inhibitor. However, it also unselectively inhibited class I and class IIb HDACs. To enhance the compound’s selectivity towards cl...
Saved in:
| Main Authors: | Kai-Cheng Hsu, Yun-Yi Huang, Jung-Chun Chu, Yu-Wen Huang, Jing-Lan Hu, Tony Eight Lin, Shih-Chung Yen, Jing-Ru Weng, Wei-Jan Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2024.2406025 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Histone Deacetylase Family: Structural Features and Application of Combined Computational Methods
by: Antonio Curcio, et al.
Published: (2024-05-01) -
Histone Deacetylase 6 (HDAC6) in Ciliopathies: Emerging Insights and Therapeutic Implications
by: Zhiyi Wang, et al.
Published: (2025-06-01) -
Targeting histone deacetylase 6 mediates a dual anti‐melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
by: K.V. Woan, et al.
Published: (2015-08-01) -
Anticancer efficacy of Spiruchostatin A: current insights into histone deacetylase inhibition and oncologic applications
by: Saooda Ibrahim, et al.
Published: (2025-03-01) -
Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostat
by: Tamara Zenz, et al.
Published: (2025-02-01)